Source: Annual Congress 2002 - Empyema thoracis in children

Abstract

Empyema can be a significant problem if it is not recognised and treated promptly.
The aim of this study was to determine the clinical value of the lung tests in early detection of dysfunction of pulmonary system post parapneumonic effusion and empyema.
59 patients post parapneumonic effusion or empyema underwent a lung test including spirography, spirometry and body pletysmography. All results were standardised and Standardised Deviation Score (SDS) were counted. Whole group of patient was divided into three subgroups: with parapneumonic effusion,empyema and fibrothorax. All patients were followed up by approximetly 6,45 years. 10 were treated by decortication. To determine influence of some parameters on pulmonary function whole group was divided into groups: age of onset, diagnosis, therapeutic management, days of hospitalisation, days of chest tube drainage, affected side.
Results
Significant differences were seen in dependence on:
- age of onset - RV to TLC ratio was lower in-group of patients youngest than 2 years old;
- diagnosis - FVC was lower and RV and RV to TLC ratio were higher in subgroup of patients with fibrothorax;
- therapeutic management-FVC was lower and RV to TLC ratio was higher in subgroup of patients treated with decortication;
- days of hospitalisation -FVC was lower and RV to TLC ratio was higher in group of patients hospitalised more than 30 days;
Analysis of whole group in dependence of days of chest tube drainage, affected side reveals no significant differences.
Conclusion
1. In-patients post parapneumonic effusions and empyema dysfunction of pulmonary system is observed.
2. In some cases restriction or obstructive disturbances were observed.
3. Significant differences were detected between group treated by decortication and treated by another methods (i.g. chest tube drainage)

Rating:

Share or cite this content

Citations should be made in the following way:
J. Lange, J. Peradzyńska, M. Kulus, J. Ziolkowski (Warsaw, Poland). Lung function in children post parapneumonic effusion and empyema. Eur Respir J 2002; 20: Suppl. 38, 3695

Member's Comments

No comment yet.

Related content which might interest you: Role of pulmonary scintigraphy in children post parapneumonic effusion and empyema Source: Eur Respir J 2001; 18: Suppl. 33, 170s Year: 2001 Management of parapneumonic effusion and empyema in children Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002 Late period pulmonary functions of the patients who were treated for parapneumonic effusion and empyema Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Treatment results of patients with complicated parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Lung function of preschoolers with parapneumonic effusions complicating community acquired pneumonia Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 Pleural empyema in children Source: Eur Respir Monogr 2013; 61: 153-161 Year: 2013 Parapneumonic effusion and empyema Source: Respipedia Article Year: 2017 Predictors of outcome in parapneumonic pleural effusions in children Source: Eur Respir J 2001; 18: Suppl. 33, 171s Year: 2001 Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011 Treatment of parapneumonic pleural effusion and empyema: conservative view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199 Year: 2004 Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Infectious pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204 Year: 2002 Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Prognostic features of residual pleural thickening in parapneumonic pleural effusions Source: Eur Respir J 2003; 21: 952-955 Year: 2003 Pleural infection and empyema Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders Year: 2012 Update on the management of parapneumonic pleural effusions Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021